The Board of Directors of Nova Wellness Group Berhad wishes to announce the positive results from the recently completed Hepar-P clinical trial to assess its efficacy and safety in patients with Non-Alcoholic Fatty Liver Disease (NAFLD).
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
donkeycharles
98 posts
Posted by donkeycharles > 2021-02-24 22:16 | Report Abuse
if i sell my shares tmr on ex date, am i still entitled for the div?